Industry News

People With Eating Disorders Are Being Prescribed Ozempic — and the Results Are Dire

June 12, 2024
Popsugar writer Emilia Benton discusses the problematic practice of some physicians prescribing GLP-1 agonist medications, like Ozempic, to treat eating disorders. In this article, Dr. Elizabeth Wassenaar shares her concerns and the impact of GLP-1 agonist medications on the eating disorder community. "Eating disorders are one of the most fatal mental illnesses; anorexia specifically has the hightest mortality rate of any psychiatric disorder. This makes prescribing a medication that can potentially trigger disordered eating behavior all the more concerning," said Dr. Wassenaar.

Read the Full Article from POPSUGAR

If you've followed health and wellness news and trends over the last couple of years, you're likely familiar with the drug Ozempic, which appears to promise dramatic results for individuals wanting to lose a significant amount of weight.

The glucagon-like peptide 1, or GLP-1, drug is a fairly new medication that was originally approved by the Food and Drug Administration in 2017 for the treatment of type 2 diabetes. It was designed to improve blood sugar, along with diet and exercise, possibly leading to weight loss.

Read More

Eating Recovery Center is accredited through the Joint Commission. This organization seeks to enhance the lives of the persons served in healthcare settings through a consultative accreditation process emphasizing quality, value and optimal outcomes of services.

Organizations that earn the Gold Seal of Approval™ have met or exceeded The Joint Commission’s rigorous performance standards to obtain this distinctive and internationally recognized accreditation. Learn more about this accreditation here.

Joint Commission Seal